date:Mar 04, 2014
sed by 4.6 per cent of $3.4 million in the six months to 31 December 2013. WCB said this reflected the positive cash flow from operations partially offset by the investment in a new Lactoferin plant commissioned in January 2014.
Earnings per share of 56.1 cents reflected the improved overall earnings position.
No interim dividend has been declared as the Director foresee cash being retained for reinvestment into the business for growth, investment and development.
WCBs Board said it should be